Peter P Yu, MD - Medicare Internal Medicine in Hartford, CT

Peter P Yu, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Hartford, Connecticut. His current practice location is 80 Seymour St, Hartford Hospital Cancer Center, Hartford, Connecticut. You can reach out to his office (for appointments etc.) via phone at (860) 972-4161.

Peter P Yu is licensed to practice in Connecticut (license number 55846) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1982610515.

Contact Information

Peter P Yu, MD
80 Seymour St, Hartford Hospital Cancer Center,
Hartford, CT 06102-8000
(860) 972-4161
(860) 545-4079



Physician's Profile

Full NamePeter P Yu
GenderMale
SpecialityInternal Medicine - Hematology & Oncology
Location80 Seymour St, Hartford, Connecticut
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1982610515
  • Provider Enumeration Date: 08/01/2006
  • Last Update Date: 02/24/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 7012935034
  • Enrollment ID: I20170123001002

Medical Identifiers

Medical identifiers for Peter P Yu such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1982610515NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology G64602 (California)Secondary
207RH0003XInternal Medicine - Hematology & Oncology 55846 (Connecticut)Primary
207RH0003XInternal Medicine - Hematology & Oncology 151810 (New York)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Peter P Yu allows following entities to bill medicare on his behalf.
Entity NameHartford Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1407806391
PECOS PAC ID: 2567366016
Enrollment ID: O20031125000700

News Archive

Most promising drugs in development for metabolic syndrome

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that emerging agents from Metabolex/Johnson & Johnson, Merck, Novartis, and Amylin/Eli Lilly are among the most promising drugs in development for metabolic syndrome.

New research shows bacterial biofilms are stronger than single-celled bacteria

New research from the University of Copenhagen reveals that bacteria which agglutinate before entering the body are far more resistant than single-celled bacteria. This may be the cause of chronic infections.

Researchers resolve long-standing mystery of enzyme's role in cell survival

St. Jude Children's Research Hospital solves mystery of enzyme's role in cell survival, offering clues of how immune system fights infection and possible strategies to treat problems ranging from heart attack to cancer.

AI can help recognize individuals with congenital adrenal hyperplasia based on facial images

Researchers at the VISTA Center (Vision, Image, Speech and Text Analytics) at the USC Viterbi Information Sciences Institutealong with scholars at the Keck School of Medicine of USC and Children's Hospital Los Angeles have discovered strong correlations between facial morphology and congenital adrenal hyperplasia (CAH), a life-threatening genetic condition of the adrenal glands and one of the most common forms of adrenal insufficiency in children.

Read more Medical News

› Verified 9 days ago

Entity NameHartford Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1770696643
PECOS PAC ID: 2567366016
Enrollment ID: O20031125000752

News Archive

Most promising drugs in development for metabolic syndrome

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that emerging agents from Metabolex/Johnson & Johnson, Merck, Novartis, and Amylin/Eli Lilly are among the most promising drugs in development for metabolic syndrome.

New research shows bacterial biofilms are stronger than single-celled bacteria

New research from the University of Copenhagen reveals that bacteria which agglutinate before entering the body are far more resistant than single-celled bacteria. This may be the cause of chronic infections.

Researchers resolve long-standing mystery of enzyme's role in cell survival

St. Jude Children's Research Hospital solves mystery of enzyme's role in cell survival, offering clues of how immune system fights infection and possible strategies to treat problems ranging from heart attack to cancer.

AI can help recognize individuals with congenital adrenal hyperplasia based on facial images

Researchers at the VISTA Center (Vision, Image, Speech and Text Analytics) at the USC Viterbi Information Sciences Institutealong with scholars at the Keck School of Medicine of USC and Children's Hospital Los Angeles have discovered strong correlations between facial morphology and congenital adrenal hyperplasia (CAH), a life-threatening genetic condition of the adrenal glands and one of the most common forms of adrenal insufficiency in children.

Read more Medical News

› Verified 9 days ago

Entity NameThe Hospital Of Central Connecticut At New Britain General And Bradley
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1063461481
PECOS PAC ID: 6507776564
Enrollment ID: O20040115000497

News Archive

Most promising drugs in development for metabolic syndrome

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that emerging agents from Metabolex/Johnson & Johnson, Merck, Novartis, and Amylin/Eli Lilly are among the most promising drugs in development for metabolic syndrome.

New research shows bacterial biofilms are stronger than single-celled bacteria

New research from the University of Copenhagen reveals that bacteria which agglutinate before entering the body are far more resistant than single-celled bacteria. This may be the cause of chronic infections.

Researchers resolve long-standing mystery of enzyme's role in cell survival

St. Jude Children's Research Hospital solves mystery of enzyme's role in cell survival, offering clues of how immune system fights infection and possible strategies to treat problems ranging from heart attack to cancer.

AI can help recognize individuals with congenital adrenal hyperplasia based on facial images

Researchers at the VISTA Center (Vision, Image, Speech and Text Analytics) at the USC Viterbi Information Sciences Institutealong with scholars at the Keck School of Medicine of USC and Children's Hospital Los Angeles have discovered strong correlations between facial morphology and congenital adrenal hyperplasia (CAH), a life-threatening genetic condition of the adrenal glands and one of the most common forms of adrenal insufficiency in children.

Read more Medical News

› Verified 9 days ago

Entity NameMidstate Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1154425288
PECOS PAC ID: 7416840699
Enrollment ID: O20040203000244

News Archive

Most promising drugs in development for metabolic syndrome

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that emerging agents from Metabolex/Johnson & Johnson, Merck, Novartis, and Amylin/Eli Lilly are among the most promising drugs in development for metabolic syndrome.

New research shows bacterial biofilms are stronger than single-celled bacteria

New research from the University of Copenhagen reveals that bacteria which agglutinate before entering the body are far more resistant than single-celled bacteria. This may be the cause of chronic infections.

Researchers resolve long-standing mystery of enzyme's role in cell survival

St. Jude Children's Research Hospital solves mystery of enzyme's role in cell survival, offering clues of how immune system fights infection and possible strategies to treat problems ranging from heart attack to cancer.

AI can help recognize individuals with congenital adrenal hyperplasia based on facial images

Researchers at the VISTA Center (Vision, Image, Speech and Text Analytics) at the USC Viterbi Information Sciences Institutealong with scholars at the Keck School of Medicine of USC and Children's Hospital Los Angeles have discovered strong correlations between facial morphology and congenital adrenal hyperplasia (CAH), a life-threatening genetic condition of the adrenal glands and one of the most common forms of adrenal insufficiency in children.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Peter P Yu is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Peter P Yu, MD
80 Seymour St, Hartford Hospital Cancer Center,
Hartford, CT 06102-8000

Ph: (860) 972-4161
Peter P Yu, MD
80 Seymour St, Hartford Hospital Cancer Center,
Hartford, CT 06102-8000

Ph: (860) 972-4161

News Archive

Most promising drugs in development for metabolic syndrome

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that emerging agents from Metabolex/Johnson & Johnson, Merck, Novartis, and Amylin/Eli Lilly are among the most promising drugs in development for metabolic syndrome.

New research shows bacterial biofilms are stronger than single-celled bacteria

New research from the University of Copenhagen reveals that bacteria which agglutinate before entering the body are far more resistant than single-celled bacteria. This may be the cause of chronic infections.

Researchers resolve long-standing mystery of enzyme's role in cell survival

St. Jude Children's Research Hospital solves mystery of enzyme's role in cell survival, offering clues of how immune system fights infection and possible strategies to treat problems ranging from heart attack to cancer.

AI can help recognize individuals with congenital adrenal hyperplasia based on facial images

Researchers at the VISTA Center (Vision, Image, Speech and Text Analytics) at the USC Viterbi Information Sciences Institutealong with scholars at the Keck School of Medicine of USC and Children's Hospital Los Angeles have discovered strong correlations between facial morphology and congenital adrenal hyperplasia (CAH), a life-threatening genetic condition of the adrenal glands and one of the most common forms of adrenal insufficiency in children.

Read more News

› Verified 9 days ago


Internal Medicine Doctors in Hartford, CT

Gagandeep Singh, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 114 Woodland St, Hartford, CT 06105
Phone: 860-714-7446    Fax: 860-714-1508
Yixia Ye, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 31 Seymour St Ste 205, Hartford, CT 06106
Phone: 860-524-2610    
Andrew P Scatola, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 85 Jefferson Street, Hartford Hospital Cardiology Dept, Hartford, CT 06106
Phone: 860-972-1212    
Dr. David Jay Altszuler, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 85 Seymour St Ste 719, Hartford, CT 06106
Phone: 860-522-0604    Fax: 860-522-0604
Dr. Nisha Dhanabalsamy, MBBS
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 80 Seymour St, Hartford, CT 06102
Phone: 860-972-0549    
Sindhuja Palle, MD
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 80 Seymour St, Hartford, CT 06106
Phone: 860-545-5000    
Dr. Jamie Matthew Roche, M.D.
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 80 Seymour St, Hartford, CT 06102
Phone: 860-545-3359    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.